Canaan, NY, United States of America

Harry P Schane, Jr


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Canaan, NY (US) (1980)
  • Chatham, NY (US) (1982)

Company Filing History:


Years Active: 1980-1982

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Harry P. Schane, Jr.

Introduction

Harry P. Schane, Jr. is a notable inventor based in Canaan, NY, whose work has significantly contributed to the field of pharmacology. With a total of two patents to his name, he has made strides in developing compounds aimed at influencing adrenal function in primates.

Latest Patents

Among his latest patents, Schane has focused on the compound 4.alpha.,5.alpha.-Epoxy-3,20-dioxopregnan-2.alpha.,16.alpha.-dicarbonitrile. This compound is synthesized by decyclizing 4.alpha.,5.alpha.-epoxy-20-oxopregn-2-eno-[2,3-d]isoxazole-16.alpha.-carnitrile with a strong base. It serves as an inhibitor of mineralocorticoid production and action without concurrently inhibiting glucocorticoids in primates. Another significant patent involves a method for suppressing pituitary-adrenal function without creating peripheral glucocorticoid effects. This method includes administering an effective dose of (17.alpha.)-2'-(4-fluorophenyl)-2'H-pregna-2,4-dien-20-yno[3,2-c]-pyrazol-17-ol to reduce circulating hydrocortisone levels.

Career Highlights

Harry P. Schane, Jr. is affiliated with Sterling Drug Inc., where he has had the opportunity to explore and validate his innovative ideas. His contributions in research and development have positioned him as a key figure within his organization, enabling him to push the boundaries of pharmaceutical development.

Collaborations

Throughout his career, Schane has collaborated with esteemed colleagues such as Homer R. Harding and John E. Creange. These partnerships have fostered an environment of innovation, allowing for the exchange of ideas and techniques that enhance their collective research endeavors.

Conclusion

Harry P. Schane, Jr. exemplifies the spirit of innovation in the pharmaceutical industry. With his groundbreaking patents and valuable collaborations, he continues to pave the way for advancements that may significantly impact medical treatments and quality of life for countless individuals. His work remains a testament to the importance of research and development in addressing complex biological challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…